Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Elamipretide hydrochloride by Stealth BioTherapeutics for Barth Syndrome: Likelihood of Approval
Elamipretide hydrochloride is under clinical development by Stealth BioTherapeutics and currently in Pre-Registration for Barth Syndrome. According to GlobalData, Pre-Registration...
Elamipretide hydrochloride by Stealth BioTherapeutics for Mitochondrial Myopathy: Likelihood of Approval
Elamipretide hydrochloride is under clinical development by Stealth BioTherapeutics and currently in Phase III for Mitochondrial Myopathy. According to GlobalData,...
Elamipretide hydrochloride by Stealth BioTherapeutics for Geographic Atrophy: Likelihood of Approval
Elamipretide hydrochloride is under clinical development by Stealth BioTherapeutics and currently in Phase II for Geographic Atrophy. According to GlobalData,...
Elamipretide hydrochloride by Stealth BioTherapeutics for Dry (Atrophic) Macular Degeneration: Likelihood of Approval
Elamipretide hydrochloride is under clinical development by Stealth BioTherapeutics and currently in Phase II for Dry (Atrophic) Macular Degeneration. According...
Elamipretide hydrochloride by Stealth BioTherapeutics for Friedreich Ataxia: Likelihood of Approval
Elamipretide hydrochloride is under clinical development by Stealth BioTherapeutics and currently in Phase II for Friedreich Ataxia. According to GlobalData,...